Saris­sa tight­ens its grip on Amarin as CEO re­signs

Saris­sa Cap­i­tal gained an­oth­er foothold in its takeover of Amarin with the de­par­ture of the Irish drug­mak­er’s CEO.

Amarin re­vealed Fri­day in an SEC fil­ing that Karim Mikhail re­signed as pres­i­dent and CEO ear­li­er this week. How­ev­er, there’s still an on­go­ing dis­pute be­tween Mikhail and Amarin, with the now ex-CEO in­sist­ing that he has a claim to sev­er­ance as a re­sult of his res­ig­na­tion. How­ev­er, Amarin says it dis­agrees and plans to dis­pute that claim.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER